SENOKOT
Pronunciation: SEN-a

What it isPlant-derived anthraquinone laxative activated by colonic bacteria; constipation.
Why this oneUnlike docusate, it reliably promotes bowel movements and is routinely paired with opioids from the start.
What limits itCramping is common. Melanosis coli with chronic use is benign and reversible; evidence does not support the old cathartic-colon fear.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Constipation | Adults & children ≥12 yr | 2 tablets QD-BID | 2 tablets BID | |
| Constipation | Children 6-<12 yr | 1 tablet QD-BID | 1 tablet BID |
Renal Undefined
Hepatic Undefined
Available strengths
Pregnancy Undefined
Lactation Undefined
| Strength | #/mo | generic $/mo | brand $/mo | CostPlus | |
|---|---|---|---|---|---|
| 8.6 mg | tab | 30 qd | $0.77 | — | not offered |
| 15 mg | tab | 30 qd | $2.60 | — | not offered |
| 17.2 mg | tab | 30 qd | — | $12.49 | not offered |
| 25 mg | tab | 30 qd | $3.49 | — | not offered |
Available combined with: senna / docusate
NO BOXED WARNINGS
Principal riskCramping; melanosis coli with chronic use
Defining liabilityCramping, diarrhea and misuse-related fluid/electrolyte losses